#stifel
Latest news and interesting information about stifel.
Texas Instruments director sells $3.2M in stock
Texas Instruments director Martin S. Craighead sold $3.2 million in stock. TXN shares surged 72% over the past year but may be overvalued.
Equillium SVP & COO sells $267,209 in shares
Equillium COO Christine Zedelmayer sells $267,209 in shares. Analysts optimistic about EQ504 drug pipeline.
Klaviyo co-CEO sells over $3.1M in stock
Klaviyo co-CEO Andrew Bialecki sold 212,529 shares for $3.1M. The stock is down 56% over the past year.
Texas Roadhouse executive sells $89,430 in shares
Texas Roadhouse (TXRH) Chief Business Officer Christopher Colson sells 499 shares worth $89,430. Company reports strong Q1 results and analyst upgrades.
Stifel Reinstates Clean Harbors with Buy Rating
Stifel reinstated Clean Harbors with a Buy rating and $337 target. Learn about the company's market leadership, growth catalysts, and recent acquisitions.
Werner Enterprises stock hits 52-week high at $41.50
Werner Enterprises stock hits 52-week high of $41.50, with 59.46% annual return. Analysts revise earnings up. Read more on Bond.az.
Levi Strauss 10% owner Robert D. Haas sells over $4.5m in shares
Levi Strauss 10% owner Robert D. Haas sold over $4.5 million in shares. Get transaction details and analysis on Bond.az.
Braze stock: AI demand drives growth
Stifel reiterates Buy rating on Braze stock with $30 target, citing AI demand growth and revenue increase.
Rosenblatt Raises Marvell Target to $240 on AI
Rosenblatt raised Marvell Technology's price target to $240, citing AI growth. Revenue and EPS estimates increased above consensus.
10x Genomics CFO sells $369K in stock
10x Genomics CFO Adam Taich sold $369,017 worth of stock. Shares have surged 197% in the past year. New partnerships and market shifts analyzed.
Guidewire CEO sells $166,212 in stock
Guidewire CEO Michael Rosenbaum sold $166,212 worth of company stock. Shares have fallen 36% in six months; analysts have mixed views.
Cohu CFO Sells $608,920 in Stock
Cohu CFO Jeffrey Jones sold $608,920 worth of stock. Company revenue beat estimates, secured $5M DiamondX orders. Analysts raised price targets.
Taco Bell CEO sells $464,040 in YUM stock
Taco Bell CEO Sean Tresvant sells $464,040 worth of YUM Brands stock. He now holds 3,140 shares. Strong quarterly results reported.
Wolfe Research Reaffirms Ionis Stock Outperform Rating
Wolfe Research reiterates Outperform rating on Ionis Pharmaceuticals stock. Analysis of Arrowhead competition and financial results.
FormFactor director sells $484K in stock
FormFactor director Rebeca Obregon-Jimenez sells $484,146 in stock. Company reports strong quarterly results. Analysis on Bond.az.
Cohu Director Sells $460,026 in Common Stock
Cohu director Steven Bilodeau sold $460,026 in common stock. Shares have surged 169% over the past year. Analysts raise price targets.
Texas Instruments stock hits record $310.53
Texas Instruments stock hits all-time high of $310.53. Analyst targets range from $300 to $400. Strong performance driven by AI and data center demand.
Summit Therapeutics Analysis: Cantor Fitzgerald Backs Overweight
Cantor Fitzgerald reiterates Overweight on Summit Therapeutics. HARMONi-3 trial miss and analyst views covered by Bond.az.
Stifel reiterates IBM Buy after $1bn Chips Act award
Stifel reiterates IBM Buy rating after $1bn Chips Act award for quantum computing. Stock up 15%.
Stifel Maintains Buy on Deckers Outdoor at $140
Stifel reiterates Buy rating on Deckers Outdoor with $140 target. Stock shows strong growth potential and attractive valuation.
Nlight CEO sells $9.2m in shares
Nlight CEO Scott Keeney sells $9.2 million worth of shares. Prices ranged from $68.48 to $76.46. Company reports strong Q1 results.
H.B. Fuller Offers 285p for AMSU
H.B. Fuller offers 285p per share for Advanced Medical Solutions. Discussions ongoing.
Semtech Stock Hits Record High: $149.4
Semtech Corporation stock hits all-time high of $149.34. 1-year gain 268%, market cap $13.81B. Analyst upgrades and new product launch.
Stifel raises Nvidia price target to $282
Stifel raises Nvidia price target to $282, maintaining Buy rating after strong Q1 results and promising market outlook.
Immunovant director sells $192,000 in shares
Immunovant director Atul Pande sold $192,000 worth of shares. Stock up 147% in past year, but company remains unprofitable.
Klaviyo CEO sells $2.98M in shares
Klaviyo co-CEO Andrew Bialecki sold 200,000 shares for $2.98M. Stock down 54% in past year. Bond.az analysis suggests undervaluation.
Snap CAO Sells $114,142 in Company Stock
Snap CAO Rebecca Morrow sold $114,142 in company stock at $5.46-$5.74 per share. Full details on Bond.az.
Bob R Simpson TXO Partners director buys $1.97m
TXO Partners director Bob R Simpson buys $1.97 million in common units. Shares up 31% YTD; analysts maintain $19-$22 target.
Stifel Initiates Eupraxia with Buy Rating
Stifel initiated coverage on Eupraxia Pharmaceuticals with a Buy rating and $25 target. Diffusphere platform and strong finances highlighted.
Why CrowdStrike stock is surging
CrowdStrike stock rallies on analyst upgrades, strong partner metrics, and a new European partnership ahead of June 3 earnings. Shares hit a 52-week high.
...